ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CELC vs CDNA // FORWARD P/E MULTIPLE

Celcuity Inc. (NASDAQ) VS. CareDx Inc. (NASDAQ) • 15-METRIC TALLY: CELC 0 — CDNA 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELC VS. CDNA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CELC CDNA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -8.20% -26.80 CDNA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -4.53% 0.67% -5.20 CDNA /fcf-yield <GO>
Operating Margin — -8.10% — TIE /operating-margins <GO>
Net Profit Margin — -5.60% — TIE /net-margins <GO>
Revenue Growth (YoY) — 13.80% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 19.22 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 CDNA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.7 54.9 -5.20 CDNA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.06 — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 21.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.39B $3.70B -$309.1M CDNA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CELC REV CDNA REV CELC GROSS % CDNA GROSS % CELC FCF CDNA FCF
FY 2025 $0 $379.8M — — -$153.5M $24.9M
FY 2024 $0 $333.8M — — -$83.7M $23.0M
FY 2023 $0 $280.3M — — -$53.8M -$31.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CELC // BETA —
CDNA // BETA 1.06